circulating tumour dna for decision making in high risk and metastatic bladder cancer
Published 2 years ago • 309 plays • Length 5:41Download video MP4
Download video MP3
Similar videos
-
45:19
can circulating tumour dna guide treatment intensification in de novo metastatic prostate cancer?
-
13:35
eau24: eautv on bladder cancer
-
52:46
"circulating tumour dna: an increasingly powerful diagnostic tool for oncology" - nitzan rosenfeld
-
5:10
circulating tumor dna (ctdna) to reshape clinical trial design in early stage cancers
-
0:34
cfdna for mrd detection in non-muscle invasive bladder cancer
-
12:01
debate: is circulating tumor dna ready to guide adjuvant therapy in colon cancer? - yes
-
1:48
circulating tumor dna - bladder cancer video library
-
1:05:10
future roles for liquid biopsies in clinical decision making in uro-oncology
-
31:29
eau tv: the best on bladder cancer and renal cell carcinoma on day three of eau21
-
2:36
imvigor010 & imvigor011: ctdna as a response biomarker for adjuvant atezolizumab in high-risk mibc
-
2:47
the role of ctdna in bladder cancer - bladder cancer video library
-
3:25
ctdna in metastatic bladder cancer - bladder cancer video library
-
4:43
imvigor011: atezolizumab for ctdna-positive patients with high-risk muscle invasive bladder cancer
-
5:07
significance of serial circulating tumor dna alterations in metastatic urothelial carcinoma therapy
-
6:00
circulating tumor dna in metastatic prostate cancer
-
3:47
cell-free utdna may predict transurethral resection of bladder tumour pathology in nmibc
-
1:17
exploring ctdna in muscle-invasive bladder cancer: future applications and current limitations
-
1:36
liquid biopsies and tumor-informed ctdna profiling in metastatic urothelial carcinoma
-
45:31
risk stratification in utuc: past, present, and future